Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Regulatory FDF Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 474
2019 Revenue in Millions : 278
Growth (%) : 71
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 587
2020 Revenue in Millions : 474
Growth (%) : 24
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 536
2021 Revenue in Millions : 587
Growth (%) : -9
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 508
2022 Revenue in Millions : 536
Growth (%) : -5
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 443
2023 Revenue in Millions : 508
Growth (%) : -13
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 76
2017 Revenue in Millions : 6
Growth (%) : 1167%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 278
2018 Revenue in Millions : 76
Growth (%) : 266
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Patents & EXCLUSIVITIES
ABOUT THIS PAGE
